Platelets harness the immune response to drive liver cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 32, 2012, Pages 12840-12841

  Maini, Mala K ^a   Schurich, Anna ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; CD40 LIGAND; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; MESSENGER RNA;

CANCER MORTALITY; CD8+ T LYMPHOCYTE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; INCIDENCE; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; TRANSGENE; VACCINATION; VIRUS HEPATITIS; VIRUS LOAD;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B, CHRONIC; LIVER NEOPLASMS; PLATELET AGGREGATION INHIBITORS;

HARNESS;

EID: 84864709258     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1210296109     Document Type: Note

References (16)

1. Yang JD, Roberts LR (2010) Hepatocellular carcinoma: A global view. Nature reviews. Gastroenterol Hepatol 7:448-458.
2. Sitia G, et al. (2012) Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B. Proc Natl Acad Sci USA 109:E2165-E2172.
3. Dandri M, Locarnini S (2012) New insight in the pathobiology of hepatitis B virus infection. Gut 61:6-17.
4. Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23-61.
5. Thimme R, et al. (2003) CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77:68-76. (Pubitemid 36004947)
6. Kakimi K, et al. (2001) Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J Exp Med 194:1755-1766. (Pubitemid 34028655)
7. Maini MK, et al. (2000) The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191:1269-1280. (Pubitemid 30227116)
8. Iannacone M, et al. (2005) Platelets mediate cytotoxic T lymphocyte-induced liver damage. Nat Med 11:1167-1169. (Pubitemid 43093662)
9. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV (1998) Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188:341-350. (Pubitemid 28357762)
10. Denis MM, et al. (2005) Escaping the nuclear confines: Signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122:379-391. (Pubitemid 41127140)
11. Semple JW, Italiano JE, Jr., Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264-274.
12. Elzey BD, et al. (2003) Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19:9-19. (Pubitemid 36859897)
13. Henn V, et al. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591-594. (Pubitemid 28157601)
14. Tripodi A, Mannucci PM (2011) The coagulopathy of chronic liver disease. N Engl J Med 365:147-156.
15. McMorran BJ, et al. (2009) Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science 323:797-800.
16. Rothwell PM, et al. (2012) Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: Analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 379:1602-1612.